Specifically, blockade of the immune checkpoint CD73 enhanced the cytotoxicity of NKG2D-targeting CAR-NK-92 cells in CD73+ human lung cancer xenograft models (128). This evidence concerns the gene KLRK1 and lung carcinoma.